Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD)

NCT01668186 is registered in ClinicalTrials.gov with McGill University Health Centre/Research Institute of the McGill University Health Centre as lead sponsor.

NCT NCT01668186
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01668186 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Longitudinal Natural History Study of Patients With Peroxisome Biogenesis Disorders (PBD)
Lead sponsor
McGill University Health Centre/Research Institute of the McGill University Health Centre
Phase
Observational
Overall status
Recruiting
Start date
January 31, 2012
Completion date
January 31, 2031
Enrollment
244 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acbd5 (acylcoa binding domain 5) deficiency, adult refsum disease, alpha-methylacyl-coa racemase deficiency, atp binding cassette subfamily d member 3 gene mutation, d-bifunctional protein deficiency, peroxisomal acyl-coa oxidase 2 deficiency, peroxisomal acyl-coa oxidase deficiency, peroxisome biogenesis disorder, rcdp - rhizomelic chondrodysplasia punctata, sterol carrier protein 2 deficiency, zellweger spectrum disorder